BACKGROUND: Since the ATP-binding cassette transporter ABCG2 plays a physiologically significant role of porphyrin efflux from living cells, the expression of ABCG2 may influences the efficacy of photodynamic therapy (PDT). In this study, we evaluated the effect of gefitinib, a potent ABCG2 inhibitor, on 5-aminolevulinic acid (5-ALA)-PDT in brain tumor cell lines in vitro. MATERIALS AND METHODS: Four human glioma cell lines (U87MG, U118MG, A172, and T98G) and a malignant meningioma cell line (IOMM-Lee) were incubated with gefitinib (0.01-1.0μM) before incubation with 5-ALA (1mM). The effects gefitinib on intracellular protoporphyrin IX (PpIX), mRNA and protein expression of ABCG2, and PDT were evaluated, in vitro. RESULTS: At concentrations of 0.1μM or higher, gefitinib enhanced intracellular levels of PpIX in a dose-dependent manner in all those cell lines. Gefitinib decreased mRNA and plasma membrane protein expression of ABCG2, and efficiently enhanced the effect of 5-ALA-PDT in malignant brain tumor cells. CONCLUSION: Gefitinib can inhibit ABCG2-mediated PpIX efflux from malignant brain tumor cells to increase the intracellular PpIX and thereby enhance the PDT effect.
BACKGROUND: Since the ATP-binding cassette transporter ABCG2 plays a physiologically significant role of porphyrin efflux from living cells, the expression of ABCG2 may influences the efficacy of photodynamic therapy (PDT). In this study, we evaluated the effect of gefitinib, a potent ABCG2 inhibitor, on 5-aminolevulinic acid (5-ALA)-PDT in brain tumor cell lines in vitro. MATERIALS AND METHODS: Four humanglioma cell lines (U87MG, U118MG, A172, and T98G) and a malignant meningioma cell line (IOMM-Lee) were incubated with gefitinib (0.01-1.0μM) before incubation with 5-ALA (1mM). The effects gefitinib on intracellular protoporphyrin IX (PpIX), mRNA and protein expression of ABCG2, and PDT were evaluated, in vitro. RESULTS: At concentrations of 0.1μM or higher, gefitinib enhanced intracellular levels of PpIX in a dose-dependent manner in all those cell lines. Gefitinib decreased mRNA and plasma membrane protein expression of ABCG2, and efficiently enhanced the effect of 5-ALA-PDT in malignant brain tumor cells. CONCLUSION:Gefitinib can inhibit ABCG2-mediated PpIX efflux from malignant brain tumor cells to increase the intracellular PpIX and thereby enhance the PDT effect.
Authors: Eva Christine Bunk; Andrea Wagner; Walter Stummer; Volker Senner; Benjamin Brokinkel Journal: J Neurooncol Date: 2021-01-03 Impact factor: 4.130
Authors: Yan Baglo; Barry J Liang; Robert W Robey; Suresh V Ambudkar; Michael M Gottesman; Huang-Chiao Huang Journal: Cancer Lett Date: 2019-05-06 Impact factor: 8.679
Authors: Joshua Bakhsheshian; Matthew D Hall; Robert W Robey; Michelle A Herrmann; Jin-Qiu Chen; Susan E Bates; Michael M Gottesman Journal: Drug Metab Dispos Date: 2013-07-18 Impact factor: 3.922
Authors: Evgenii Belykh; Nikolay L Martirosyan; Kaan Yagmurlu; Eric J Miller; Jennifer M Eschbacher; Mohammadhassan Izadyyazdanabadi; Liudmila A Bardonova; Vadim A Byvaltsev; Peter Nakaji; Mark C Preul Journal: Front Surg Date: 2016-10-17
Authors: Elmire Hartmans; Matthijs D Linssen; Claire Sikkens; Afra Levens; Max J H Witjes; Gooitzen M van Dam; Wouter B Nagengast Journal: Oncotarget Date: 2017-05-02
Authors: Joshua Bakhsheshian; Bih-Rong Wei; Ki-Eun Chang; Suneet Shukla; Suresh V Ambudkar; R Mark Simpson; Michael M Gottesman; Matthew D Hall Journal: Proc Natl Acad Sci U S A Date: 2013-12-02 Impact factor: 11.205